CA2244807A1 - Vaccin produit a partir de salmonella typhimurium - Google Patents

Vaccin produit a partir de salmonella typhimurium Download PDF

Info

Publication number
CA2244807A1
CA2244807A1 CA002244807A CA2244807A CA2244807A1 CA 2244807 A1 CA2244807 A1 CA 2244807A1 CA 002244807 A CA002244807 A CA 002244807A CA 2244807 A CA2244807 A CA 2244807A CA 2244807 A1 CA2244807 A1 CA 2244807A1
Authority
CA
Canada
Prior art keywords
typhimurium
strain
avirulent
fad
pathogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002244807A
Other languages
English (en)
Inventor
David P. Franklin
David C. Laux
Paul S. Cohen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhode Island Department of Elementary and Secondary Education
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2244807A1 publication Critical patent/CA2244807A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/255—Salmonella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne un vaccin vivant protégeant contre un pathogène microbien, qui est avirulent, essentiellement incapable de se multiplier dans l'hôte et qui ne comporte aucun risque de se reconvertir en souche virulente sauvage.
CA002244807A 1996-02-15 1997-02-13 Vaccin produit a partir de salmonella typhimurium Abandoned CA2244807A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60179096A 1996-02-15 1996-02-15
US08/601,790 1996-02-15

Publications (1)

Publication Number Publication Date
CA2244807A1 true CA2244807A1 (fr) 1997-08-15

Family

ID=24408780

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002244807A Abandoned CA2244807A1 (fr) 1996-02-15 1997-02-13 Vaccin produit a partir de salmonella typhimurium

Country Status (5)

Country Link
EP (1) EP0894005A1 (fr)
JP (1) JP2000504726A (fr)
AU (1) AU2120197A (fr)
CA (1) CA2244807A1 (fr)
WO (1) WO1997029768A1 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0943681A1 (fr) * 1998-01-22 1999-09-22 Vrije Universiteit Brussel Vaccin à base de Salmonella vivant atténué
WO1999037759A2 (fr) * 1998-01-22 1999-07-29 Vrije Universiteit Brussel Vaccin vivant attenue contre la salmonelle
US7193017B2 (en) 2004-08-13 2007-03-20 Univation Technologies, Llc High strength biomodal polyethylene compositions
US7312279B2 (en) 2005-02-07 2007-12-25 Univation Technologies, Llc Polyethylene blend compositions
US7947797B2 (en) 2005-09-14 2011-05-24 Univation Technologies, Llc Method for operating a gas-phase reactor at or near maximum production rates while controlling polymer stickiness
US7935355B2 (en) 2007-04-19 2011-05-03 Nutritional Health Institute Laboratories, Llc Composition and method for controlling intestinal pathogenic organisms
US20080260777A1 (en) 2007-04-19 2008-10-23 Sotomayor Konky Composition and method for controlling intestinal pathogenic organisms
EP2112175A1 (fr) 2008-04-16 2009-10-28 ExxonMobil Chemical Patents Inc. Activateur de métallocènes comprenant au moins un ligand hétérocyclique substitué par halogène, coordonné à un alumoxane
TW200936619A (en) 2007-11-15 2009-09-01 Univation Tech Llc Polymerization catalysts, methods of making, methods of using, and polyolefin products made therefrom
WO2011103280A1 (fr) 2010-02-18 2011-08-25 Univation Technologies, Llc Procédés d'exploitation d'un réacteur de polymérisation
RU2563032C2 (ru) 2010-02-22 2015-09-20 Юнивейшн Текнолоджиз, Ллк Каталитические системы и способы их применения для получения полиолефиновых продуктов
US8722804B2 (en) 2010-04-13 2014-05-13 Univation Technologies, Llc Polymer blends and films made therefrom
RU2564301C2 (ru) 2010-07-16 2015-09-27 Юнивейшн Текнолоджиз, Ллк Системы и способы измерения накопления частиц на поверхностях реактора
WO2012009215A1 (fr) 2010-07-16 2012-01-19 Univation Technologies, Llc Systèmes et procédés pour mesurer la charge statique portée par des particules
WO2012015898A1 (fr) 2010-07-28 2012-02-02 Univation Technologies, Llc Systèmes et procédés pour mesurer la vitesse d'un mélange particule/fluide
CN103298842B (zh) 2010-12-17 2016-08-31 尤尼威蒂恩技术有限责任公司 从聚烯烃吹扫气体产物回收烃的系统以及方法
WO2013028283A1 (fr) 2011-08-19 2013-02-28 Univation Technologies, Llc Systèmes de catalyseur et leurs procédés d'utilisation pour la production de produits de polyoléfine
WO2013070602A1 (fr) 2011-11-08 2013-05-16 Univation Technologies, Llc Procédés pour la production de polyoléfines avec des systèmes de catalyseur
ES2798272T3 (es) 2011-11-08 2020-12-10 Univation Tech Llc Métodos de preparación de un sistema catalítico
EP2938434B1 (fr) 2012-12-28 2022-05-04 Univation Technologies, LLC Catalyseur supporté ayant un écoulement amélioré
JP6359034B2 (ja) 2013-02-07 2018-07-18 ユニベーション・テクノロジーズ・エルエルシー ポリオレフィンの調製
CN105143280B (zh) 2013-03-15 2017-06-13 尤尼威蒂恩技术有限责任公司 催化剂的配体
JP6360549B2 (ja) 2013-03-15 2018-07-18 ユニベーション・テクノロジーズ・エルエルシー オレフィン重合触媒用の三座窒素系配位子
US9604893B2 (en) 2013-06-05 2017-03-28 Univation Technologies, Llc Protecting phenol groups
US10711072B2 (en) 2015-04-17 2020-07-14 Univation Technologies, Llc Methods and systems for olefin polymerization
SG11201708487RA (en) 2015-04-24 2017-11-29 Univation Tech Llc Methods for operating a polymerization reactor
WO2018048472A1 (fr) 2016-09-09 2018-03-15 Exxonmobil Chemical Patents Inc. Opération de semi-condensation à échelle d'usine pilote
WO2018118258A1 (fr) 2016-12-20 2018-06-28 Exxonmobil Chemical Patents Inc. Procédés de réglage des conditions de démarrage dans des processus de polymérisation
US11447587B2 (en) 2018-05-02 2022-09-20 Exxonmobil Chemical Patents Inc. Methods for scale-up from a pilot plant to a larger production facility
EP3788082A1 (fr) 2018-05-02 2021-03-10 ExxonMobil Chemical Patents Inc. Procédés d'extrapolation d'une installation pilote à une installation de production plus grande
WO2024129637A1 (fr) 2022-12-12 2024-06-20 Univation Technologies, Llc Réduction de la charge triboélectrique et/ou de l'encrassement d'un réacteur par des particules de polyoléfine

Also Published As

Publication number Publication date
JP2000504726A (ja) 2000-04-18
WO1997029768A1 (fr) 1997-08-21
AU2120197A (en) 1997-09-02
EP0894005A1 (fr) 1999-02-03

Similar Documents

Publication Publication Date Title
EP0894005A1 (fr) Vaccin a base de salmonella typhimurium
EP0368966B1 (fr) Nouveaux vaccins vivants reversibles de shigella
US5210035A (en) Non-reventing live vaccines
US6399074B1 (en) Live attenuated salmonella vaccines to control avian pathogens
US5643771A (en) Non-reverting live bacterial vaccines
Coynault et al. Virulence and vaccine potential of Salmonella typhlmurium mutants deficient in the expression of the RpoS (σs) regulon
AU584963B2 (en) Non-reverting double mutant salmonella live vaccines
US5855880A (en) Avirulent microbes and uses therefor
EP0563311B1 (fr) Vaccins ameliores
EP0500699B1 (fr) Vaccins de protection croisee contre la salmonella
US20060233829A1 (en) Regulated attenuation of live vaccines to enhance cross-protective immunogenicity
US6902906B1 (en) Bacteria attenuated by a non-reverting mutation in each of the aroC, ompF and ompC genes, useful as vaccines
AU666108B2 (en) CDT mutants of salmonella typhi
EP0465561A1 (fr) Microbes avirulents et leurs emplois
WO1997020033A1 (fr) Vaccins contre les salmonelles
MXPA00009354A (en) Bacteria attenuated by a non-reverting mutation in each of the aroc, ompf and ompc genes, useful as vaccines

Legal Events

Date Code Title Description
FZDE Dead